NEU 1.30% $19.71 neuren pharmaceuticals limited

Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-35

  1. 1,154 Posts.
    lightbulb Created with Sketch. 130
    Spot on Guzz!

    and it's been like this for a long time, and even after our recent success is still proving to be a respectful and great 'family' to be a part of
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.